Aeonian Biotech Ltd

South East, United Kingdom

Short Summary

A retail to supply the best research reagents to the IVD and CDx industries and to research facilities, based on disruptive proprietary. Orders have commenced and global recognition reached. Our aim is 1% of global market worth £7 billion.


Investment Raised
Previous Rounds N/A
Stage Achieving Sales
Investor Role Monthly Involvement


  • We have contracted a well-established distributor for better exposure.
  • The first sales went through that distributor, proving effectiveness.
  • Repeat order confirms a happy customer.
  • Second manufacturer contracted.
  • Third manufacturer in negotiation.
Please note: The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
100% raised

Medical Facility Portugal

location_on London, United Kingdom

It is estimated that European countries combine to become the world’s largest regulated medical cannabis market over the next five years. 30% Return over 24 months- Paid 12% Yr 1 & 18% Yr 2. We will send the full company bio on self cert evidence.

£ 4,000,000


£ 20,000

Min per Investor

0% raised

Sound. Translated.

location_on London, United Kingdom

We are reframing all notions of hearing loss towards the new lenses of Hearing Gains. Our core mission is to reduce the 5 to 10 year delay between early signs of hearing reduction to permanent solution, to ideally 6 months.

£ 300,000


£ 5,000

Min per Investor

20% raised


location_on East Anglia, United Kingdom

Hügge. A 3-year old sleep brand admired by its customers. Harrods launch in 2017; 4.9/5 review score, EIS, validated business model, 2k+ mattresses sold, raised £162k+ crowdfund equity ( 2017), FCA approved, NBF award winner, DTC & B2B

£ 250,000


£ 10,000

Min per Investor

load one similar proposal